Researcher interests: Signal transduction, Signal transduction therapy,Cancer Research, Medicinal Chemistry.
FACULTY / SCHOOL: Faculty of Science
Contact Business Development: Shani Bullock

Selected Publications

efrat flashnerabramson, jianmin, Alexander Levitzki, mor gal, rachel lee, roger daly, shihping, Shoshana Klein
impact of the anticancer drug nt157 on tyrosine kinase signaling networks (2018)| Molecular Cancer Therapeutics| Read more
Alexei Shir, idit sagivbarfi, Alexander Levitzki, maya zigler, nufar edinger, Shoshana Klein, Tamar Geiger, yael langut
s101 an inhibitor of proliferating t cells rescues mice from superantigen induced shock (2018)| The Journal of Infectious Diseases| Read more
alaa talhami, Alexei Shir, anna sagalov, efrat flashnerabramson, Alexander Levitzki, maya zigler, nufar edinger, salim joubran, samarasimhareddy mamidi, Shoshana Klein, yael langut
psma targeted polyinosine polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice (2017)| Proceedings of the National Academy of Sciences of the United States of America| Read more
efrat flashnerabramson, Alexander Levitzki, Mario Lebendiker, naomi melamedbook, nufar edinger, Shoshana Klein, yael langut, yael levikalisman
psma homing dsrna chimeric protein vector kills prostate cancer cells and activates anti tumor bystander responses (2017)| Oncotarget| Read more
amos zehavi, aviv gazit, Yinon Ben-Neriah, Alexander Levitzki, mordechai anafi, yinon benneriah
t yr p ho s t in i nd uced in hi bi t ion of p 2 1 obcr ab tyrosine kinase activity induces k562 to differentiate (2017)| | Read more
Alexander Levitzki, Mario Lebendiker, maya zigler, nufar edinger, Shoshana Klein, yael langut
targeting polyic to egfr over expressing cells using a dsrna binding protein domain tethered to egf (2016)| PLOS ONE| Read more
Alexei Shir, efrat flashnerabramson, Hadas Reuveni, langut, Alexander Levitzki, menashe bareli, mullin, renduo song, shoshan, Shoshana Klein
targeting melanoma with nt157 by blocking stat3 and igf1r signaling (2016)| Oncogene| Read more
efrat flashnerabramson, elsa sanchezlopez, Koji Taniguchi, Alexander Levitzki, Michael Karin, shabnam shalapour, zhenyu zhong
targeting colorectal cancer via its microenvironment by inhibiting igf 1 receptor insulin receptor substrate and stat3 signaling (2016)| Oncogene| Read more
Hadas Reuveni, haruhito azuma, ladan fazli, Alexander Levitzki, martin gleave, mazyar ghaffari, michael cox, mitali pandey, naokazu ibuki
abstract b51 the tyrphostin nt157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer (2015)| Molecular Cancer Therapeutics| Read more
Hadas Reuveni, haruhito azuma, ladan fazli, Alexander Levitzki, martin gleave, mazyar ghaffari, michael cox, mitaly pandey, naokazu ibuki
mp46 08 the tyrphostin nt157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer (2015)| The Journal of Urology| Read more
transmembrane signaling in saccharomyces cerevisiae as a model for signaling in metazoans state of the art after 25 years (2014)| Cellular Signalling| Read more
Nataly Kravchenko-Balasha, Alexander Levitzki, nataly kravchenkobalasha, Noam Cohen, Shoshana Klein
heterogeneity of gene expression in murine squamous cell carcinoma development the same tumor by different means (2013)| PLOS ONE| Read more

Contact for more information:

Shani Bullock
VP, Business Development, Healthcare
+972-2-6586608
Contact ME: